in the industry as the “Alpha Scientist,”
Dr. Allen is in the forefront of scientific breakthroughs,
including Nanotechnology, NanoMolecules, Quantum Chocolate,
Genetic polymorphisms in Dysregulated Arginine Metabolism,
Sickle Cell Polymorphisms, Thalassemia, Blind Amino
Acid Riders, L-Arginine Isoform Pathways, and Edible
30+ Years of Clinical Research
of Biomedical Research
Glycemic Research Institute®
of Clinical Research
Children’s Obesity & Diabetes
Human In Vivo Clinical Trials
Type I Adult Diabetes
Obesity & Adipose Tissue Fat-Storage
Glycemic Research Laboratories
Skinny Science® Research
Skinny Science® EDU
Edible Computer Chips
of Nanoparticle Science
Blood Brain Barrier Research
of Orthomolecular & Nutraceutical Research
of Clinical Research
Director of Research & Development
Global Genetic Solutions
Division of Sickle Cell & Thalassemia
medical and research community states that Dr. Allen's
science and technology is "Twenty years ahead
of everyone else."
Known in the industry for her bold
stance of setting high standards in scientific accuracy,
Dr. Allen went so far as to correct Discover magazine,
whose educational publication is considered the gold
standard in science. Her
statement on quaternary saturated amines prompted
a correction by Discover.
For over twenty years, Dr. Allen
had warned of the dangers of using L-arginine without
a Blind Amino Acid Rider. Her stance on L-arginine
was validated in January 2006, when the Journal of
the American Medical Association (JAMA) published
the Johns Hopkins clinical trial on oral L-arginine,
in which L-arginine was shown to cause death in a
significant segment of the subjects, which prompted
the close of the clinical trial.
As a result of her long-term research
on the amino acid L-arginine, the medical and scientific
community refered to Dr. Allen as the Leader in L-Arginine
Biochemistry, and the Queen of Arginine.
When Dr. Allen was asked by the media
how she is able to stay on the leading edge of future-science,
“Part science, part skill,
and part intuition. I also credit my savant-dyslexia.
A dyslexic’s nonlinear images allows them to
think much more quickly and multi-dimensionally. Albert
Einstein was savant-dyslexic. Einstein was able to
develop his theory of relativity due to his dyslexic
properties of creativity and ability to make intuitive
leaps. Intuitive leaps allow me to ignore conventional
science and make theoretical bonds with nutritional
concepts. The key then, is to scientifically prove
As a tribute to Einstein, in 1983
Dr. Allen named her L-Arginine Isoform Pathway L-Arginine
Announced by Medical Community
Top Researchers Break the Code to
Genetic Diseases Sickle Cell &
Ann de Wees Allen Addresses the United Nations
General Assembly in New York City
group of top scientists, named “The
Dream Team” have discovered the Key
Code to a new treatment for Sickle Cell Disease and
Thalassemia, the number one genetic disease in the
Fellow researchers named the group The Dream Team
due to their groundbreaking research and discoveries
in the field of NutraGenomics.
globally as one of the most important discoveries
of this century, researchers say that “This
discovery may well be worthy of the Nobel Prize in
goal is to harness the power of Nutritional Genomics.
We aim to understand genetic variations in the metabolism
of specific nutrients, beginning with L-Arginine,
and to develop methodologies specifically addressing
and ameliorating genetic variants.”
OVER $ 1 BILLION DOLLARS
IN PATENTS & TECHNOLOGY
scientifically and financially, Dr. Ann de Wees Allen®
has reset the standard definition of success.
page of the Wall Street Journal, “Breakthrough
Product of the Year” by Success magazine,
“First Glycemic Patent Ever Awarded Worldwide”,
First Scientist to Address the United Nations
General Assembly on L-Arginine (Sickle Cell Conference),
Who’s Who of American Inventors .
. . these are the accolades of renowned researcher,
Dr. Ann de Wees Allen®.
With more than one
Billion dollars generated from global
licensing of Dr. Allen’s Patents and technology,
financial experts are paying close attention to
the next discovery that evolves from Dr. Ann de
Wees Allen’s laboratory.
As Chief of Biomedical Research
at the Glycemic Research Institute®,
and Chief Scientist at Skinny Science®
Corporation, Dr. Allen’s 25-year history
of clinical research has produced a plethora of
cutting-edge Edible Computer Chips®
that are designed to address anti-aging, diabetes,
and the current childhood and adult obesity epidemic.
The breakthrough technology and
products developed by Dr. Allen’s research
team focus on the Glycemic Index and include Skinny
Science® Coffee, Skinny
Science® Ice Cream, and Skinny
Science® Chocolate, all of which
are designed to be Low Glycemic, Non-Cephalic
(Brain Glycemic Indexing), and to avert storage
in human fat cells.
Skinny Science® foods,
beverages and sweet-treats are specifically designed
to be guilt-free, all-natural (no artificial sweeteners),
Diabetic Friendly®, Kid Friendly®, and
Diet Friendly. So, who wouldn’t want chocolate
and ice cream that tastes great, is natural, and
designed to avoid fat-storage?
Romero becomes the youngest person in the world to
scale Mount Everest, the world's tallest mountain.
Glycemic Research Institute & Dr. Ann de Wees
Allen Sponsor Jordan Romero on Mount Everest.
Science ® Researchers discover why Artificial
Sweeteners & Diet Sodas
Here for Dr. Allen's live Newscast at
Clear Channel |
Recognizes Benefits of
The Glycemic Index
American Diabetes Association (July 2008) embraced
the results of a huge clinical trial at Harvard School
of Public Health, and the benefits of the glycemic
In a study of more than 85,000 people over a 20-year
period, the Glycemic Index was validated in preventing
Type 2 diabetes and obesity.
for over 2 decades, “Women had a 250 percent
higher risk of developing type 2 diabetes if they
consistently ate foods high in Glycemic Load, like
sugar-sweetened fruit juice, refined sugary cereal,
carb smart helps keep diabetes at bay”
Glycemic Research Institute®
601 Pennsylvania Avenue
N.W. Suite 900
Washington, D.C. 20004
number of overweight children aged 6-11 has more
than doubled in the past 20 years. Current estimates
show that 32 percent of U.S. children are overweight,
while 16 percent are obese.
are struggling to control and prevent their children
from becoming yet another statistic in the obesity/diabetes
are now predicting that one of every two children
will develop Type 2 diabetes because of excess weight,
which raises the probability that they will die
as much as 20 years younger than their parents.
in the United States are completely surrounded by
fattening foods and beverages. Even infant formulas
contain added sugar, so from birth, children are
ingesting ingredients that increase the size of
fat cells and trigger fat cells to increase in number.
creation of an abundance of fat cells in children
makes it almost impossible for that child to maintain
normal weight or to lose weight as the child grows.
By age 18, the stage has already been set for a
child to be slim or obese.
DR. ANN de WEES ALLEN RECEIVES UNITED STATES PATENT ON WORLD'S FIRST FAT-BURNING COFFEE
Researcher and Scientist, Dr. Ann de Wees Allen® has received a Patent on the World's First Fat-Burning Coffee.
Dr. Allen started working on a new invention for a mechanism which switched any form of plain coffee to a Fat-Burning Coffee in 1983.
She subsequently filed a patent on Fat-Burning Coffee, Fat-Burning Tea, Fat-Burning Water, and numerous other fat-burning products, and was issued a full U.S. patent. Dr. Allen's patent attorney is now the Director of the United States Patent & Trademark Office(USPTO.gov).
Dr. Allen has licensed her Fat-Burning Coffee and Fat-Burning Tea to various companies since the 1980's, which has generated multi-millions of dollars in sales.
Her Fat-Burning Coffee was named Breakthrough Product of the Year by Success Magazine and was featured on the cover of the Wall Street Journal for having generated over $$ 300 Million Dollars - and that was before her Fat-Burning Coffee really took off.
Dr. Allen holds the exclusive manufacturing rights to her Proprietary coffee and tea compound which is the key to making safe and effective Fat-Burning products, as well as legal claims on Fat-Burning Coffee or Tea.
Proprietary Trade Secrets, unlike patents, trademarks and copyrights, are defined and governed by individual state law and are recognized in every U.S. state. This allows inventors, like Dr. Allen, to defend and protect their Proprietary Trade Secrets.
Dr. Allen's Proprietary Trade Secrets, related to Fat-Burning Coffee, have never been revealed, thus assuring that the original and authentic Fat-Burning Coffee remains a Proprietary Trade Secret.
UPDATE: Dr. Allen continues to successfully license her Fat-Burning technology to the Nutraceutical industry, and is currently working on a new methodology in coffee research. She will have Board Approved Human In Vivo Clinical Trials completed featuring this new technology in 2014.
This article originated at:
Science ® is a branch of biomedical research that
refers to weight management in humans, adipose tissue
fat-storage, fat-storing mechanisms, Cephalic effect,
thermogenic fat-burning, and Low Glycemic methodologies.
Dr. Allen's Skinny Science ® Research Team has
discovered the KEY CODE
for fat-storage in the fat cell, identifying which
foods store in human fat cells and which foods do
not store in fat cells, and why diet sodas are more
fattening than a bowl of sugar.
Ann de Wees Allen
Skinny Science ® Biomedical Team
Human In Vivo Clinical Research
Utilizing State-of-the-Art methodologies
in Nutritional Genomics, foods, beverages, nutrients,
and proteins can now be safely designed to encode transporters,
receptors, carrier proteins, enzymes and hormones.
Nutrigenomic scientists, this means that they can begin
to construct a picture of dietary interactions from
the level of body composition and whole-body physiology,
from substrate-flux through metabolic pathways, to the
amount and activity of crucial enzymes, and on, down
to the effects of gene expression.
Nutritional Genomics in Protein Research
of the Art Nanotechnology
and Red Blood Cells
Research Institute® has been conducting Human
Clinical In Vivo Trials in the field of diabetes for
the past 23 years. This picture represents Nanotechnology
in diabetes research.
Blood-Brain-Barrier Nanoparticle Paths of
its neuroprotective role, the blood-brain-barrier
(BBB) blocks agents from entering
protective mechanism has been in place since man first
walked the earth. If this mechanism was not in place,
the brain would self-destruct within a few weeks,
as invaders, including natural sugars, foods, and
amino acids, would cause a biochemical implosion capable
of killing the host (the human body).
Manufacturing at the nanoscale involves the
industrial application of nanotechnologies.
term Edible Computer Chip®
has recently gained popularity in the
Nutraceutical and Pharmaceutical fields.
Though Edible Computer Chips®
sound like they may describe a futuristic
robotic-chip that programs the human
body to follow specific commands, that
is not the case.
Computer Chip® are not synthetic,
nor do they contain any non-food grade or unsafe ingredients.
They are manufactured and produced from non-GMO ingredients,
organic fruit and FDA acceptable food and beverage